New FACTT technique is conservatively over 1000-times more sensitive than ELISA.
D014408:Biomarkers, Tumor; D001774:Blood Chemical Analysis / Q000379:methods*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D005455:Fluorescent Antibody Technique / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D007124:Immunoenzyme Techniques / Q000295:instrumentation / Q000379:methods; D018739:Oncogene Proteins v-erbB / Q000378:metabolism; D012680:Sensitivity and Specificity; D012698:Serologic Tests
D014408:Biomarkers, Tumor; D018739:Oncogene Proteins v-erbB